Winarski: Apple repurposed Siri in 2010 to serve Apple Calendar and Mail
Norman Winarski · The Future of AI and Entrepreneurship, According Two Leading Innovators · Jan 13, 2025 · at 13:23
Siri co-founder Norman Winarski explains how Steve Jobs and Apple adapted Siri's technology after acquiring the company in 2010.
0:00 / 0:18exact quote · 18.0s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Apple purchased Siri Steve Jobs, and they, in 2010, they took Siri as it was and reinvented it for the Apple purposes, so that would access Apple Calendar, Apple Mail, All of those things.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Norman Winarski
Winarski: Voice will not be the primary interface for AI
“I disagree that voice is going to be the primary way that we're going to interact with AR.”
Winarski: Text will remain a dominant AI interaction form for a long time
“Text is going to be a dominant form, and for a long time.”
Winarski: Foundation AI giants will never sufficiently focus on market verticals
“So from my point of view, I believe that these big companies will never try to focus sufficiently on the market verticals that will really make a huge difference to that particular market, and so the industry will flourish in each of these individual markets.”
Winarski: Users will stop interacting directly with standalone mobile app interfaces
“So I do think that everybody will have their own Application business, but I don't think we'll see it the same way as we do today with your iPhone or Android phone.”
Winarski: In five years, AI will yield vertical monopolies and novel cancer therapies
“Five years from now, we will, first of all, see major industries that have formed in each of these market verticals that are dominating those verticals. And we'll also have seen some incredible new science come out. Biotech with cancer treatments and discovery…”